NO20073764L - Sammensetninger for behandling av HCV - Google Patents

Sammensetninger for behandling av HCV

Info

Publication number: NO20073764L
Authority: NO; Norway
Prior art keywords: hcv; compositions; treatment; agent; compound
Prior art date: 2004-12-23

Application number

NO20073764A

Other languages

English (en)

Norwegian (no)

Inventor

Kai Lin

Beat Weidmann

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-23

Filing date

2007-07-19

Publication date

2007-09-18

2007-07-19 Application filed by Novartis Ag filed Critical Novartis Ag

2007-09-18 Publication of NO20073764L publication Critical patent/NO20073764L/no

Links

239000000203 mixture Substances 0.000 title 1
102000001493 Cyclophilins Human genes 0.000 abstract 1
108010068682 Cyclophilins Proteins 0.000 abstract 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
229930105110 Cyclosporin A Natural products 0.000 abstract 1
108010036949 Cyclosporine Proteins 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229930182912 cyclosporin Natural products 0.000 abstract 1
230000001506 immunosuppresive effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/21—Interferons [IFN]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Natural Medicines & Medicinal Plants (AREA)
Gastroenterology & Hepatology (AREA)
Virology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Botany (AREA)
Medical Informatics (AREA)
Microbiology (AREA)
Mycology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Alternative & Traditional Medicine (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Peptides Or Proteins (AREA)

NO20073764A 2004-12-23 2007-07-19 Sammensetninger for behandling av HCV NO20073764L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US63867504P	2004-12-23	2004-12-23
PCT/US2005/046059 WO2006071619A1 (fr)	2004-12-23	2005-12-20	Compositions pour le traitement du vhc

Publications (1)

Publication Number	Publication Date
NO20073764L true NO20073764L (no)	2007-09-18

Family

ID=36155247

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20073764A NO20073764L (no)	2004-12-23	2007-07-19	Sammensetninger for behandling av HCV

Country Status (16)

Country	Link
US (1)	US7897565B2 (fr)
EP (1)	EP1830871A1 (fr)
JP (1)	JP2008525459A (fr)
KR (1)	KR20070087624A (fr)
CN (1)	CN101076350A (fr)
AU (1)	AU2005322242B2 (fr)
BR (1)	BRPI0519345A2 (fr)
CA (1)	CA2587793A1 (fr)
IL (1)	IL183659A0 (fr)
MA (1)	MA29098B1 (fr)
MX (1)	MX2007007779A (fr)
NO (1)	NO20073764L (fr)
NZ (1)	NZ555143A (fr)
RU (1)	RU2007128099A (fr)
WO (1)	WO2006071619A1 (fr)
ZA (1)	ZA200703908B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0320638D0 (en)	2003-09-03	2003-10-01	Novartis Ag	Organic compounds
BRPI0513370A (pt)	2004-07-14	2008-05-06	Novartis Ag	uso de uma combinação de ciclosporina e interferonas peguilados para tratamento de hepatite c (hcv)
WO2006071618A1 (fr) *	2004-12-23	2006-07-06	Novartis Ag	Composes pour le traitement des infections virales par flaviviridae
CA2587793A1 (fr)	2004-12-23	2006-07-06	Novartis Ag	Compositions pour le traitement du vhc
AR054778A1 (es) *	2005-06-17	2007-07-18	Novartis Ag	Uso de sangliferina en hcv
EP1909564A4 (fr) *	2005-07-18	2010-06-30	Novartis Ag	Modele petit animal pour une replication hcv
US8329658B2 (en)	2005-09-30	2012-12-11	Scynexis, Inc.	Arylalkyl and heteroarylalkyl derivatives of cyclosporine A for the treatment and prevention of viral infection
BRPI0616476A2 (pt)	2005-09-30	2011-06-21	Scynexis Inc	uso de uma quantidade terapeuticamente eficaz de um derivado de ciclosporina, e, composição farmacêutica
JP2007112775A (ja) *	2005-10-24	2007-05-10	Hamamatsu Univ School Of Medicine	サイトメガロウイルス感染の処置におけるシクロスポリン類の使用
ATE502633T1 (de)	2006-05-19	2011-04-15	Scynexis Inc	Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
BRPI0719189A2 (pt) *	2006-10-12	2018-08-14	Univ Kyushu Nat Univ Corp	uso de ciclosporinas modificadas
US7576057B2 (en)	2006-11-20	2009-08-18	Scynexis, Inc.	Cyclic peptides
US9090671B2 (en)	2008-06-06	2015-07-28	Scynexis, Inc.	Macrocyclic peptides
EP2376524B1 (fr)	2008-12-31	2017-03-15	Cypralis Limited	Dérivés de cyclosporine a
US10752611B2 (en)	2009-02-27	2020-08-25	Enanta Pharmaceuticals, Inc.	Benzimidazole derivatives
BR112012010110A2 (pt)	2009-10-30	2019-09-24	Boehringer Ingelheim Int	regimes de dosagem para terapia combinada para hcv compreendendo bi201335, interferon alfa e ribavirina
BR112012014729A2 (pt) *	2009-12-18	2016-03-29	Boehringer Ingelheim Int	terapia combinada contra hcv
KR20140035305A (ko)	2010-10-05	2014-03-21	노파르티스 아게	C형 간염 바이러스 감염의 새로운 치료법
BR112013013166A2 (pt)	2010-11-30	2016-09-06	Novartis Ag	tratamentos da infecção pelo vírus da hepatite c
JO3337B1 (ar)	2010-12-13	2019-03-13	Debiopharm Sa	تركيبات صيدلية تشمل أليسبوريفير
CN105749246A (zh)	2011-03-31	2016-07-13	诺华股份有限公司	治疗丙肝病毒感染的阿拉泊韦
PL2694087T3 (pl)	2011-04-01	2015-06-30	Novartis Ag	Leczenie zakażenia wirusem zapalenia wątroby typu B samego lub w połączeniu z zakażeniem wirusem zapalenia wątroby typu delta i towarzyszącymi chorobami wątroby
SG10201602184TA (en)	2011-04-13	2016-04-28	Novartis Ag	Treatment of hepatitis c virus infection with alisporivir
KR20140070565A (ko)	2011-09-27	2014-06-10	노파르티스 아게	C형 간염 바이러스 감염의 치료를 위한 알리스포리비르
SG11201406441RA (en)	2012-05-07	2014-11-27	Novartis Ag	Pharmacokinetic modulation with alisporivir
WO2015008223A1 (fr)	2013-07-17	2015-01-22	Novartis Ag	Traitement du virus de l'hépatite c avec l'alisporivir et la ribavirine
TW201536789A (zh)	2013-07-29	2015-10-01	Enanta Pharm Inc	Ｃ型肝炎病毒抑制劑
WO2015136455A1 (fr)	2014-03-13	2015-09-17	Novartis Ag	Nouveaux traitements d'une infection par le virus de l'hépatite c
EP4483875A3 (fr)	2016-05-10	2025-04-02	C4 Therapeutics, Inc.	Dégronimères spirocycliques pour la dégradation de protéines cibles
EP3455219A4 (fr)	2016-05-10	2019-12-18	C4 Therapeutics, Inc.	Dégronimères de c3-glutarimide liés à une amine pour la dégradation de protéines cibles
CN109641874A (zh)	2016-05-10	2019-04-16	C4医药公司	用于靶蛋白降解的c3-碳连接的戊二酰亚胺降解决定子体
CN109562107A (zh)	2016-05-10	2019-04-02	C4医药公司	用于靶蛋白降解的杂环降解决定子体
EP3641762B1 (fr)	2017-06-20	2026-02-18	C4 Therapeutics, Inc.	Dégrons et dégronimères à liaison n/o pour la dégradation de protéines

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5639724A (en)	1984-07-24	1997-06-17	Sandoz Ltd.	Cyclosporin galenic forms
ATE148469T1 (de)	1990-11-02	1997-02-15	Sandoz Ag	Zyklosporine
US5908621A (en)	1995-11-02	1999-06-01	Schering Corporation	Polyethylene glycol modified interferon therapy
FR2757522B1 (fr) *	1996-12-24	1999-01-29	Rhone Poulenc Rorer Sa	Derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2757521B1 (fr)	1996-12-24	1999-01-29	Rhone Poulenc Rorer Sa	Nouveaux derives de cyclosporine, leur preparation et les compositions pharmaceutiques qui les contiennent
JPH1180026A (ja)	1997-09-02	1999-03-23	Yoshitomi Pharmaceut Ind Ltd	新規免疫抑制剤、その使用方法およびその同定方法
US20030216303A1 (en)	1998-03-06	2003-11-20	Michael Ambuhl	Emulsion preconcentrates containing cyclosporin or a macrolide
GB9811854D0 (en) *	1998-06-02	1998-07-29	Ciba Geigy Ag	Organic compounds
AR031010A1 (es) *	2000-10-19	2003-09-03	Fujisawa Pharmaceutical Co	Una composicion farmaceutica, util para inhibir el dano celular
AR036081A1 (es) *	2001-06-07	2004-08-11	Smithkline Beecham Corp	Compuesto de 1,2-dihidroquinolina, su uso para preparar una composicion farmaceutica, metodos para prepararlo y compuestos del acido 2-aminobenzoico n-alquilado de utilidad como intermediarios en dichos metodos
US20030213603A1 (en) *	2002-05-14	2003-11-20	Fisher David B.	Dual use extension apparatus for a tool
CN1678326A (zh) *	2002-06-28	2005-10-05	埃迪尼克斯(开曼)有限公司	用于治疗黄病毒感染的2'－c－甲基－3'－o－l－缬氨酸酯核糖呋喃基胞苷
CA2503693A1 (fr) *	2002-10-29	2004-05-13	Coley Pharmaceutical Group, Ltd.	Techniques et produits relatifs au traitement et a la prevention de l'infection par le virus de l'hepatite c
RU2005123395A (ru) *	2002-12-23	2006-01-27	Айденикс (Кайман) Лимитед (Ky)	Способ получения 3-нуклеозидных пролекарств
GB0320638D0 (en) *	2003-09-03	2003-10-01	Novartis Ag	Organic compounds
UA88484C2 (ru)	2004-10-01	2009-10-26	Дебиофарм Са	ПРИМЕНЕНИЕ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИНА ДЛЯ ЛЕЧЕНИЯ ИНФЕКЦИИ ГЕПАТИТА С И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, КОТОРАЯ ВКЛЮЧАЕТ [D-MeAla]3-[EtVal]4-ЦИКЛОСПОРИН
CA2587793A1 (fr)	2004-12-23	2006-07-06	Novartis Ag	Compositions pour le traitement du vhc

2005
- 2005-12-20 CA CA002587793A patent/CA2587793A1/fr not_active Abandoned
- 2005-12-20 RU RU2007128099/15A patent/RU2007128099A/ru not_active Application Discontinuation
- 2005-12-20 WO PCT/US2005/046059 patent/WO2006071619A1/fr not_active Ceased
- 2005-12-20 KR KR1020077014269A patent/KR20070087624A/ko not_active Withdrawn
- 2005-12-20 AU AU2005322242A patent/AU2005322242B2/en not_active Ceased
- 2005-12-20 US US11/720,105 patent/US7897565B2/en not_active Expired - Fee Related
- 2005-12-20 CN CNA2005800424402A patent/CN101076350A/zh active Pending
- 2005-12-20 NZ NZ555143A patent/NZ555143A/en not_active IP Right Cessation
- 2005-12-20 MX MX2007007779A patent/MX2007007779A/es not_active Application Discontinuation
- 2005-12-20 JP JP2007548377A patent/JP2008525459A/ja active Pending
- 2005-12-20 BR BRPI0519345-1A patent/BRPI0519345A2/pt not_active IP Right Cessation
- 2005-12-20 EP EP05854722A patent/EP1830871A1/fr not_active Withdrawn
2007
- 2007-05-15 ZA ZA200703908A patent/ZA200703908B/xx unknown
- 2007-06-04 IL IL183659A patent/IL183659A0/en unknown
- 2007-06-18 MA MA30000A patent/MA29098B1/fr unknown
- 2007-07-19 NO NO20073764A patent/NO20073764L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20070087624A (ko)	2007-08-28
IL183659A0 (en)	2007-09-20
CA2587793A1 (fr)	2006-07-06
US7897565B2 (en)	2011-03-01
BRPI0519345A2 (pt)	2009-01-20
MX2007007779A (es)	2007-08-14
JP2008525459A (ja)	2008-07-17
WO2006071619A1 (fr)	2006-07-06
AU2005322242A1 (en)	2006-07-06
ZA200703908B (en)	2009-06-24
AU2005322242B2 (en)	2010-02-11
EP1830871A1 (fr)	2007-09-12
NZ555143A (en)	2009-12-24
RU2007128099A (ru)	2009-01-27
MA29098B1 (fr)	2007-12-03
US20090104149A1 (en)	2009-04-23
CN101076350A (zh)	2007-11-21

Legal Events

Date	Code	Title	Description
2011-07-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
BRPI0519345A2 (pt)	2009-01-20	composiÇço para tratamento do hcv
NO20092053L (no)	2009-07-24	HCV NS3-proteaseinhibitorer
EA200800371A1 (ru)	2008-06-30	Ингибиторы ns3 протеазы вгс
NO20070224L (no)	2007-04-02	2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
NO20091704L (no)	2009-07-27	Inhibitorer av hepatitt C virus
NO20091707L (no)	2009-05-29	Inhibitorer av hepatitt C virus
EP1802650A4 (fr)	2008-08-20	Derives de cyclosporine 3-ether et 3-thioether substitues utilises dans le traitement et la prevention d'une infection par hepatite c
NO20073765L (no)	2007-09-19	Forbindelser for behandling av flaviviridae
ATE433447T1 (de)	2009-06-15	Pyrimiidinverbindungen
NO20081086L (no)	2008-04-30	Makrosykliske peptider som HCV NS3-proteaseinhibitorer
NO20061479L (no)	2006-06-02	Anvendelse av modifiserte cyklosporiner for behandling av HCV-forstyrrelser
NO20091706L (no)	2009-07-21	Inhibitorer av hepatitt C virus
NO20050525L (no)	2005-05-06	Benzimidazol-1-yl-tiofenforbindelser for behandling av cancer
NO20080338L (no)	2008-02-29	Forbindelser for behandling av multilegemiddelresistente bakterielle infeksjoner
GB0612423D0 (en)	2006-08-02	Therapeutic agents
NO20081844L (no)	2008-05-29	Terapeutiske forbindelser
EA200702493A1 (ru)	2008-04-28	Соединения и способы лечения или предотвращения флавивирусных инфекций
NO20063449L (no)	2006-07-27	Substituerte heterocykler og deres anvendelse
NO20056192L (no)	2005-12-27	Kapaseinhibitorer og anvendelse derav
NO20070258L (no)	2007-01-15	Benzyltriazolonforbindelser som ikke-nukleoside revers transkriptase inhibitorer
EA200801997A1 (ru)	2009-04-28	Новые соединения
NO20064078L (no)	2006-09-11	Substituerte azetidinsammensetninger, deres fremstilling og anvendelse som medikamenter
TW200626585A (en)	2006-08-01	18-membered macrocycles and analogs thereof
SE0303480D0 (sv)	2003-12-19	Benzofuranes
DE60222465D1 (de)	2007-10-25	Pyrazolopyridin-derivate als antiherpesmittel